Literature DB >> 1970034

Modern vaccines. Enteric infections.

M M Levine1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1970034     DOI: 10.1016/0140-6736(90)91013-z

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Cholera.

Authors:  R H Behrens
Journal:  BMJ       Date:  1991-05-04

Review 4.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

5.  Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Ayan Dey; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

6.  A cost-effectiveness analysis of typhoid fever vaccines in US military personnel.

Authors:  T A Warren; S F Finder; K L Brier; A J Ries; M P Weber; M R Miller; R P Potyk; C S Reeves; E L Moran; J J Tornow
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

7.  Epidemiology of typhoid fever in Singapore.

Authors:  F S Yew; K T Goh; Y S Lim
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

8.  Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.

Authors:  Z Altboum; E M Barry; G Losonsky; J E Galen; M M Levine
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.

Authors:  R H Hall; G Losonsky; A P Silveira; R K Taylor; J J Mekalanos; N D Witham; M M Levine
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

10.  Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.

Authors:  F M Apter; W I Lencer; R A Finkelstein; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.